These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8293835)
1. Comparative study: Replens versus local estrogen in menopausal women. Nachtigall LE Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835 [TBL] [Abstract][Full Text] [Related]
2. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L; Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260 [TBL] [Abstract][Full Text] [Related]
3. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it. Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969 [No Abstract] [Full Text] [Related]
4. Effect of raloxifene on sexual function in postmenopausal women. Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773 [TBL] [Abstract][Full Text] [Related]
5. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy. Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488 [TBL] [Abstract][Full Text] [Related]
6. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462 [TBL] [Abstract][Full Text] [Related]
9. Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness. Henneicke-von Zepelin HH; Williams R; Havemeister W; Wigger-Alberti W; Nolte KU Wien Med Wochenschr; 2017 May; 167(7-8):189-195. PubMed ID: 28091974 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function. Hubbard GB; Carey KD; Levine H; Bachmann GA Lab Anim Sci; 1997 Feb; 47(1):36-9. PubMed ID: 9051645 [TBL] [Abstract][Full Text] [Related]
12. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980 [TBL] [Abstract][Full Text] [Related]
13. Systemic absorption and sustained effects of vaginal estrogen creams. Martin PL; Yen SS; Burnier AM; Hermann H JAMA; 1979 Dec; 242(24):2699-700. PubMed ID: 228093 [TBL] [Abstract][Full Text] [Related]
14. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Bygdeman M; Swahn ML Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418 [TBL] [Abstract][Full Text] [Related]
15. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women. Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Vale F; Rezende C; Raciclan A; Bretas T; Geber S Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740 [TBL] [Abstract][Full Text] [Related]
18. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women. Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636 [TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047 [TBL] [Abstract][Full Text] [Related]
20. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]